• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10617
Device Problem Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/17/2023
Event Type  malfunction  
Manufacturer Narrative
Device evaluated by manufacturer: a synergy ous mr 3.00 x 12mm stent delivery system (sds) was returned for analysis.Visual, tactile, microscopic, dimensional and functional analysis was performed on the device.Visual examination identified stent damage along the entire length of the stent.A stent od reading could not be obtained.A review of the manufacturing stent profile data was performed and the stent od at the time of manufacture was 0.0403 inches which is within specification.Microscopic analysis of the stent identified stent struts pulled distally and bunched at the distal section.There were signs of movement, with the stent moved over the distal markerband.Balloon cones were reviewed, and no issues were noted.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.Bumper tip showed no signs of distal tip damage.No issues identified with the hypotube shaft.No issues identified with the outer / mid-shaft sections or the inner lumen of the device.The device was successfully tracked over a recommended 0.014 inch guidewire with no issues.
 
Event Description
Reportable based on device analysis completed on 31aug2023.It was reported that crossing difficulties were encountered.The target lesion was located in the long and diffused distal left anterior descending artery with more than 95% proximal calcification.A 3.00 x 12mm synergy drug-eluting stent was introduced but failed to advance.The procedure was completed with another stent.No patient complications were reported.However, returned device analysis revealed that the stent had moved over the distal markerband.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17810526
MDR Text Key324173277
Report Number2124215-2023-48230
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Model Number10617
Device Catalogue Number10617
Device Lot Number0027464788
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/03/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/31/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/31/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age76 YR
Patient SexMale
Patient RaceAsian
-
-